In its final draft guidance, NICE recommends Victrelis (boceprevir) from Merck Inc., in combination with Roche�s Pegasus (peginterferon alfa) and...
Some patients with Chronic Hepatitis C may benefit from Victrelis (boceprevir), from Merck, though the extent of added benefit is...
-Merck Inc., has notified the FDA that it will stop selling its Victrelis (boceprevir) treatment for Hepatitis C in the...